Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach
- PMID: 29506890
- DOI: 10.1016/j.cllc.2018.01.006
Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach
Abstract
Background: Evidence favoring a multidisciplinary team (MDT) approach in the treatment of lung cancer is scarce, especially in the United States. The purpose of the present investigation was to evaluate survival outcomes of lung cancer patients treated with an MDT compared with a traditional care model.
Patients and methods: The Stony Brook Cancer Center Registry was used to identify all lung cancer cases diagnosed between 2002 and 2016. We compared survival outcomes among 1956 lung cancer patients participating in our institution's Lung Cancer Evaluation Center's (LCEC) MDT program and 2315 lung cancer patients receiving traditional care. Log-ranks tests were used to evaluate differences in the 1-, 3-, 5-, and 10-year survival outcomes between the 2 groups. To address inherent biases, Cox proportional hazard models were used to estimate the effects on survival outcomes and adjust for possible confounders. Propensity matching was also performed to account for the effects of selection bias.
Results: The 5-year survival rates in the propensity-matched sample were one third greater among LCEC patients compared with those receiving a traditional care approach (33.6% vs. 23.0%; P < .001). After adjusting for potential confounders in the multivariable propensity-matched analyses, the LCEC model demonstrated a significant beneficial effect on 5-year survival outcomes compared with the standard treatment model (hazard ratio, 0.65; 95% confidence interval, 0.54-0.77).
Conclusion: The results of the present investigation suggest an improved survival benefit from usage of an MDT model versus a traditional care model in the treatment of lung cancer. Despite the use of sophisticated statistical methods to mitigate bias in a nonrandomized study, additional research is needed to determine the extent to which an MDT approach for lung cancer influences patient outcomes.
Keywords: Health care usage; Integrated care model; Patient care models; Thoracic; Treatment approach.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Comment in
-
Making the Evidentiary Case for Universal Multidisciplinary Thoracic Oncologic Care.Clin Lung Cancer. 2018 Jul;19(4):294-300. doi: 10.1016/j.cllc.2018.05.006. Epub 2018 May 18. Clin Lung Cancer. 2018. PMID: 29934139
Similar articles
-
Lung cancer recurrence and mortality outcomes over a 10-year period using a multidisciplinary team approach.Cancer Epidemiol. 2020 Oct;68:101804. doi: 10.1016/j.canep.2020.101804. Epub 2020 Sep 4. Cancer Epidemiol. 2020. PMID: 32896806
-
Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study.Lung Cancer. 2018 Oct;124:199-204. doi: 10.1016/j.lungcan.2018.07.032. Epub 2018 Jul 23. Lung Cancer. 2018. PMID: 30268461
-
Do multidisciplinary team meetings make a difference in the management of lung cancer?Cancer. 2011 Nov 15;117(22):5112-20. doi: 10.1002/cncr.26149. Epub 2011 Apr 26. Cancer. 2011. PMID: 21523766
-
Multidisciplinary team management in thoracic oncology: more than just a concept?Eur Respir J. 2014 Jun;43(6):1776-86. doi: 10.1183/09031936.00150813. Epub 2014 Feb 13. Eur Respir J. 2014. PMID: 24525445 Review.
-
Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide.Am Soc Clin Oncol Educ Book. 2014:e461-6. doi: 10.14694/EdBook_AM.2014.34.e461. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857140 Review.
Cited by
-
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.Curr Oncol. 2023 Dec 6;30(12):10363-10384. doi: 10.3390/curroncol30120755. Curr Oncol. 2023. PMID: 38132389 Free PMC article.
-
International consensus on severe lung cancer-the first edition.Transl Lung Cancer Res. 2021 Jun;10(6):2633-2666. doi: 10.21037/tlcr-21-467. Transl Lung Cancer Res. 2021. PMID: 34295668 Free PMC article. Review. No abstract available.
-
Fostering a High-Functioning Team in Cancer Care Using the 4R Oncology Model: Assessment in a Large Health System and a Blueprint for Other Institutions.JCO Oncol Pract. 2023 Jan;19(1):e125-e137. doi: 10.1200/OP.22.00287. Epub 2022 Sep 30. JCO Oncol Pract. 2023. PMID: 36178937 Free PMC article.
-
The multidisciplinary lung cancer team meeting: increasing evidence that it should be considered a medical intervention in its own right.J Thorac Dis. 2019 Mar;11(Suppl 3):S311-S314. doi: 10.21037/jtd.2019.01.14. J Thorac Dis. 2019. PMID: 30997206 Free PMC article. No abstract available.
-
Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System.JTO Clin Res Rep. 2021 Jul 3;2(8):100203. doi: 10.1016/j.jtocrr.2021.100203. eCollection 2021 Aug. JTO Clin Res Rep. 2021. PMID: 34590046 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical